Recruiting studies: Biochemically Recurrent Prostate Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recu
Phase 2 · 1 location(s) · Mayo Clinic · NCT07073794 Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)
Phase 2 · 11 location(s) · Swiss Cancer Institute · NCT07365423 Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT05588128 SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma
Phase 3 · 6 location(s) · Mayo Clinic · NCT06205316 This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surger
Phase 2 · 1 location(s) · University of Rochester · NCT05946824 Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivati
Phase 2 · 3 location(s) · Mayo Clinic · NCT06378866 An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial
EARLY_Phase 1 · 1 location(s) · Northwestern University · NCT06813898 PSMA-RLT in Biochemically Recurrent PCa
Phase 2 · 1 location(s) · Medical University of Vienna · NCT06220188 PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
Phase 2 · 1 location(s) · Hoag Memorial Hospital Presbyterian · NCT04700332 Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Phase 3 · 342 location(s) · ECOG-ACRIN Cancer Research Group · NCT04423211 Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modificatio
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05054296 68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients
Phase 3 · 8 location(s) · Telix Pharmaceuticals (Innovations) Pty Limited · NCT05847348

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.